• search
Biotherapeutics Discovery Services Biotherapeutics Discovery Services

Biotherapeutics Discovery Services

We offer services across a wide range of therapeutic modalities or drug classes, supported by our disease and target area expertise.

We provide a wide range of discovery services for large molecules and Cell & Gene Therapy (CGT) from our state-of-the-art facility located in Hyderabad, India. At the core of our large molecule discovery services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities such as:   

Monoclonal Antibody (mAb) Antibody Drug Conjugates (ADC) Bi-specific antibodies Protein therapeutics mRNA Viral vectors Cell therapeutics  

We establish and adopt innovative technology platforms for faster solutions to complex problems throughout the biologics value chain.

Speak to our experts

Why Aurigene Biotherapeutics Discovery Services?

State-of-the-art facilities

Multiple technology platforms

Analytical assessment to ensure safety and quality

Strong framework of data integrity and traceability

Regulatory audits & compliance as per global standards

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

rightCaptcha

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen Specific T cells For Cancer Immunotherapy

An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence bypass central thymic tolerance. The success of immune checkpoint blockade...

Read More
Peptide Development and Manufacturing

Peptide Development and Manufacturing

Peptides are short chains of amino acids that are linked by peptide bonds. Several peptides linked together are called polypeptides. A protein contains one or more polypeptides. Therefore, proteins are long chains of amino acids held together by peptide bonds....

Read More
Biologics Formulation Development Flyer

Biologics Process Development Services

Our strength is built on a deep understanding of cell culture, protein chemistry and an integrated analytics platform enabling a robust, scalable and controlled process. ...

Read More
Systematic formulation design - shorten development cost & time

Systematic formulation design - shorten development cost & time

Project Challenge: Existing formulation (lower strength - 50 mg) was manufactured using direct compression process. This formulation posed poor powder flow and content uniformity issues during scale-up. Development of new strength 150 mg without any process issues was a challenge. Solution design: Preliminary pre-formulation, stress study and PSD impact assessmen...

Read More

A metal catalyst-free and one-pot synthesis of (3,4- dihydro-2H-benzo[b][1,4]oxazin-2-yl)methanol derivatives in water

2015

A robust and metal catalyst-free method has been developed for the general and green synthesis of racemic (3,4-dihydro-2H-benzo[b][1,4] oxazin-2-yl)methanol derivatives. This simple, mild and practical method involves the reaction of 2-aminophenols with ()-epichlorohydrin in the presence of NaOH in water at room temperature. The reaction features high regioselec...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack